Kiniksa Pharmaceuticals, Ltd.
Hedge Funds Holdings
Last updated:
Kiniksa Pharmaceuticals, Ltd.‘s stocks are currently a part of 76 hedge funds’ portfolios, which represents 18.42% of the total amount of its stocks outstanding. This makes up a total of 12.96M shares of Kiniksa Pharmaceuticals, Ltd.. Compared to the previous quarter, the number fell by -57.17% or -17.30M shares fewer. As for the holding position changes, 42.11% (32) of current hedge fund investors increased the number of shares held, 27.63% (21) of current holders sold a part of the shares held, and 13.16% (10) closed the holdings completely. 14 hedge funds are new holders of Kiniksa Pharmaceuticals, Ltd. stock in Q1 2023, it is 18.42% of total holders.
Hedge funds holding Kiniksa Pharmaceuticals, Ltd. (Q2 2018 – Q1 2023)
| Q2 2018 | 41 |
|---|---|
| Q3 2018 | 54 |
| Q4 2018 | 52 |
| Q1 2019 | 56 |
| Q2 2019 | 61 |
| Q3 2019 | 53 |
| Q4 2019 | 60 |
| Q1 2020 | 74 |
| Q2 2020 | 92 |
| Q3 2020 | 100 |
| Q4 2020 | 105 |
| Q1 2021 | 102 |
| Q2 2021 | 100 |
| Q3 2021 | 98 |
| Q4 2021 | 98 |
| Q1 2022 | 92 |
| Q2 2022 | 89 |
| Q3 2022 | 102 |
| Q4 2022 | 123 |
| Q1 2023 | 76 |
Hedge funds changes in Kiniksa Pharmaceuticals, Ltd. positions (Q2 2018 – Q1 2023)
| Q2 2018 | 41 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 27 | 10 | 10 | 14 | -7 |
| Q4 2018 | 9 | 16 | 15 | 11 | 1 |
| Q1 2019 | 9 | 31 | 5 | 5 | 6 |
| Q2 2019 | 12 | 26 | 14 | 5 | 4 |
| Q3 2019 | 2 | 25 | 15 | 10 | 1 |
| Q4 2019 | 17 | 23 | 11 | 10 | -1 |
| Q1 2020 | 22 | 21 | 23 | 8 | 0 |
| Q2 2020 | 25 | 46 | 13 | 7 | 1 |
| Q3 2020 | 23 | 52 | 15 | 14 | -4 |
| Q4 2020 | 20 | 38 | 29 | 14 | 4 |
| Q1 2021 | 18 | 33 | 36 | 22 | -7 |
| Q2 2021 | 14 | 38 | 31 | 16 | 1 |
| Q3 2021 | 19 | 37 | 26 | 19 | -3 |
| Q4 2021 | 19 | 40 | 27 | 21 | -9 |
| Q1 2022 | 13 | 34 | 28 | 19 | -2 |
| Q2 2022 | 7 | 36 | 25 | 9 | 12 |
| Q3 2022 | 23 | 37 | 27 | 9 | 6 |
| Q4 2022 | 29 | 42 | 35 | 7 | 10 |
| Q1 2023 | 14 | 32 | 21 | 10 | -1 |
Hedge funds changes in Kiniksa Pharmaceuticals, Ltd. stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 1,042,000 | 848,000 |
| Q3 2020 | 1,489,000 | 1,275,000 |
| Q4 2020 | 3,058,000 | 2,192,000 |
| Q1 2021 | 5,101,000 | 6,502,000 |
| Q2 2021 | 2,871,000 | 4,329,000 |
| Q3 2021 | 3,154,000 | 3,543,000 |
| Q4 2021 | 3,668,000 | 2,794,000 |
| Q1 2022 | 2,435,000 | 1,768,000 |
| Q2 2022 | 3,322,000 | 1,553,000 |
| Q3 2022 | 4,680,000 | 1,793,000 |
| Q4 2022 | 6,891,828 | 2,692,974 |
| Q1 2023 | 2,176,761,000 | 1,076,004,000 |